Detalhe da pesquisa
1.
A computationally designed inhibitor of an Epstein-Barr viral Bcl-2 protein induces apoptosis in infected cells.
Cell
; 157(7): 1644-1656, 2014 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24949974
2.
Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma.
Br J Haematol
; 176(4): 583-590, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28055107
3.
Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model.
Blood
; 125(13): 2111-9, 2015 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25628467
4.
Intracellular delivery system for antibody-Peptide drug conjugates.
Mol Ther
; 23(5): 907-917, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25669432
5.
Anti-CD45 radioimmunotherapy using (211)At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model.
Blood
; 121(18): 3759-67, 2013 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23471305
6.
Bortezomib and fenretinide induce synergistic cytotoxicity in mantle cell lymphoma through apoptosis, cell-cycle dysregulation, and IκBα kinase downregulation.
Anticancer Drugs
; 26(9): 974-83, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26237500
7.
A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphoma.
Br J Haematol
; 161(2): 183-91, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23356514
8.
Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model.
Blood
; 118(3): 703-11, 2011 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-21613259
9.
Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease.
Blood
; 116(20): 4231-9, 2010 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-20702781
10.
Androgen receptor expression in mantle cell lymphoma: Potential novel therapeutic implications.
Exp Hematol
; 49: 34-38.e2, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28115200
11.
Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers.
Cancer Res
; 76(22): 6669-6679, 2016 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27590740
12.
Quantitative single-particle digital autoradiography with α-particle emitters for targeted radionuclide therapy using the iQID camera.
Med Phys
; 42(7): 4094-105, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26133610
13.
Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft models.
PLoS One
; 10(3): e0120561, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25785845
14.
α-Imaging Confirmed Efficient Targeting of CD45-Positive Cells After 211At-Radioimmunotherapy for Hematopoietic Cell Transplantation.
J Nucl Med
; 56(11): 1766-73, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26338894
15.
A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies.
Cancer Res
; 74(4): 1179-89, 2014 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24371230
16.
Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphoma.
PLoS One
; 8(12): e82742, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24358223
17.
Blood-based detection of radiation exposure in humans based on novel phospho-Smc1 ELISA.
Radiat Res
; 175(3): 266-81, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21388270
18.
Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphoma.
Clin Cancer Res
; 17(23): 7373-82, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21976541